EUNICE MOWERY: Open Payments
NPI 1558554501 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $300 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $113 |
| Amgen Inc. | 5 | $104 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| PFIZER INC. | 2 | $43 |
| GENZYME CORPORATION | 1 | $33 |
| UCB, Inc. | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Botanix SB Inc | 1 | $20 |
Products named: OTEZLA, SKYRIZI, COSENTYX, RINVOQ, DUPIXENT, Bimzelx, LITFULO, Leqselvi.
Industry payments across FL — which companies pay providers there.
